Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

A doctor and honorary researcher at the University of Exeter is leading a campaign to make reusable insulin pens the standard for treating diabetes patients. Dr Vincent Simpson aims to cut down on ...

Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.

The Tempo pen is currently compatible with three of Lilly's insulin products, including Humalog and Lyumjev, both insulin lispro-based, and insulin glargine brand Basaglar. "Despite technological ...

Certain brands of insulin have been in shortage multiple ... more than a dozen insulin products and more than 800 million insulin pens a year. "Not only are we not winding down our work for ...